Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer

Hidefumi Kinoshita, Yan Shi, Carol Sandefur, Lorraine F. Meisner, Chawnshang Chang, Aung Choon, Catherine R. Reznikoff, G. Steven Bova, Andreas Friedl, David F. Jarrard

Research output: Contribution to journalArticle

Abstract

Advanced hormone-independent prostate cancer is characterized by a significant loss of androgen receptor (AR) expression in 20-30% of the tumors. The transcriptional block underlying this phenomenon is not known, but we have proposed that methylation of CpG sites in the AR promoter may reversibly inactivate transcription of the AR (D. F. Jarrard et al., Cancer Res., 58: 5310-5314, 1998). In this study, detailed methylation analysis using bisulfite sequencing was performed on a series of AR expression- positive and -negative prostate cancer cells. We found that methylation of several consensus sequences in the AR promoter (from -131 to -121 and +44 to +54) are tightly linked to the loss of AR expression in metastatic hormone- independent prostate cancer cell lines. These consensus sites of methylation correlate with the minimal promoter region critical for AR transcription. In human tissues, no methylation was demonstrated in normal or primary prostate cancers that express the AR. Four of 15 tumors obtained from men who had died from hormone-independent prostate cancer demonstrated a significant loss of AR expression immunohistochemically and two (50%) of these AR-negative tumors contained AR methylation. We conclude that the AR promoter contains specific CpG methylation hot spots that are markers for gene silencing. Furthermore, AR methylation may represent a phenotype important in the development of hormone independence in a subset of advanced prostate cancer in which AR expression is lost. The finding of AR methylation also represents the first report of aberrant methylation on an X-linked gene associated with a somatic male cancer.

Original languageEnglish (US)
Pages (from-to)3623-3630
Number of pages8
JournalCancer Research
Volume60
Issue number13
StatePublished - Jul 1 2000

Fingerprint

Androgen Receptors
Methylation
Prostatic Neoplasms
Hormones
Neoplasms
X-Linked Genes
Consensus Sequence
Gene Silencing
Genetic Promoter Regions

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kinoshita, H., Shi, Y., Sandefur, C., Meisner, L. F., Chang, C., Choon, A., ... Jarrard, D. F. (2000). Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Research, 60(13), 3623-3630.

Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. / Kinoshita, Hidefumi; Shi, Yan; Sandefur, Carol; Meisner, Lorraine F.; Chang, Chawnshang; Choon, Aung; Reznikoff, Catherine R.; Bova, G. Steven; Friedl, Andreas; Jarrard, David F.

In: Cancer Research, Vol. 60, No. 13, 01.07.2000, p. 3623-3630.

Research output: Contribution to journalArticle

Kinoshita, H, Shi, Y, Sandefur, C, Meisner, LF, Chang, C, Choon, A, Reznikoff, CR, Bova, GS, Friedl, A & Jarrard, DF 2000, 'Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer', Cancer Research, vol. 60, no. 13, pp. 3623-3630.
Kinoshita H, Shi Y, Sandefur C, Meisner LF, Chang C, Choon A et al. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Research. 2000 Jul 1;60(13):3623-3630.
Kinoshita, Hidefumi ; Shi, Yan ; Sandefur, Carol ; Meisner, Lorraine F. ; Chang, Chawnshang ; Choon, Aung ; Reznikoff, Catherine R. ; Bova, G. Steven ; Friedl, Andreas ; Jarrard, David F. / Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. In: Cancer Research. 2000 ; Vol. 60, No. 13. pp. 3623-3630.
@article{dd857ef34fa14ce0aae808b8973036b1,
title = "Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer",
abstract = "Advanced hormone-independent prostate cancer is characterized by a significant loss of androgen receptor (AR) expression in 20-30{\%} of the tumors. The transcriptional block underlying this phenomenon is not known, but we have proposed that methylation of CpG sites in the AR promoter may reversibly inactivate transcription of the AR (D. F. Jarrard et al., Cancer Res., 58: 5310-5314, 1998). In this study, detailed methylation analysis using bisulfite sequencing was performed on a series of AR expression- positive and -negative prostate cancer cells. We found that methylation of several consensus sequences in the AR promoter (from -131 to -121 and +44 to +54) are tightly linked to the loss of AR expression in metastatic hormone- independent prostate cancer cell lines. These consensus sites of methylation correlate with the minimal promoter region critical for AR transcription. In human tissues, no methylation was demonstrated in normal or primary prostate cancers that express the AR. Four of 15 tumors obtained from men who had died from hormone-independent prostate cancer demonstrated a significant loss of AR expression immunohistochemically and two (50{\%}) of these AR-negative tumors contained AR methylation. We conclude that the AR promoter contains specific CpG methylation hot spots that are markers for gene silencing. Furthermore, AR methylation may represent a phenotype important in the development of hormone independence in a subset of advanced prostate cancer in which AR expression is lost. The finding of AR methylation also represents the first report of aberrant methylation on an X-linked gene associated with a somatic male cancer.",
author = "Hidefumi Kinoshita and Yan Shi and Carol Sandefur and Meisner, {Lorraine F.} and Chawnshang Chang and Aung Choon and Reznikoff, {Catherine R.} and Bova, {G. Steven} and Andreas Friedl and Jarrard, {David F.}",
year = "2000",
month = "7",
day = "1",
language = "English (US)",
volume = "60",
pages = "3623--3630",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer

AU - Kinoshita, Hidefumi

AU - Shi, Yan

AU - Sandefur, Carol

AU - Meisner, Lorraine F.

AU - Chang, Chawnshang

AU - Choon, Aung

AU - Reznikoff, Catherine R.

AU - Bova, G. Steven

AU - Friedl, Andreas

AU - Jarrard, David F.

PY - 2000/7/1

Y1 - 2000/7/1

N2 - Advanced hormone-independent prostate cancer is characterized by a significant loss of androgen receptor (AR) expression in 20-30% of the tumors. The transcriptional block underlying this phenomenon is not known, but we have proposed that methylation of CpG sites in the AR promoter may reversibly inactivate transcription of the AR (D. F. Jarrard et al., Cancer Res., 58: 5310-5314, 1998). In this study, detailed methylation analysis using bisulfite sequencing was performed on a series of AR expression- positive and -negative prostate cancer cells. We found that methylation of several consensus sequences in the AR promoter (from -131 to -121 and +44 to +54) are tightly linked to the loss of AR expression in metastatic hormone- independent prostate cancer cell lines. These consensus sites of methylation correlate with the minimal promoter region critical for AR transcription. In human tissues, no methylation was demonstrated in normal or primary prostate cancers that express the AR. Four of 15 tumors obtained from men who had died from hormone-independent prostate cancer demonstrated a significant loss of AR expression immunohistochemically and two (50%) of these AR-negative tumors contained AR methylation. We conclude that the AR promoter contains specific CpG methylation hot spots that are markers for gene silencing. Furthermore, AR methylation may represent a phenotype important in the development of hormone independence in a subset of advanced prostate cancer in which AR expression is lost. The finding of AR methylation also represents the first report of aberrant methylation on an X-linked gene associated with a somatic male cancer.

AB - Advanced hormone-independent prostate cancer is characterized by a significant loss of androgen receptor (AR) expression in 20-30% of the tumors. The transcriptional block underlying this phenomenon is not known, but we have proposed that methylation of CpG sites in the AR promoter may reversibly inactivate transcription of the AR (D. F. Jarrard et al., Cancer Res., 58: 5310-5314, 1998). In this study, detailed methylation analysis using bisulfite sequencing was performed on a series of AR expression- positive and -negative prostate cancer cells. We found that methylation of several consensus sequences in the AR promoter (from -131 to -121 and +44 to +54) are tightly linked to the loss of AR expression in metastatic hormone- independent prostate cancer cell lines. These consensus sites of methylation correlate with the minimal promoter region critical for AR transcription. In human tissues, no methylation was demonstrated in normal or primary prostate cancers that express the AR. Four of 15 tumors obtained from men who had died from hormone-independent prostate cancer demonstrated a significant loss of AR expression immunohistochemically and two (50%) of these AR-negative tumors contained AR methylation. We conclude that the AR promoter contains specific CpG methylation hot spots that are markers for gene silencing. Furthermore, AR methylation may represent a phenotype important in the development of hormone independence in a subset of advanced prostate cancer in which AR expression is lost. The finding of AR methylation also represents the first report of aberrant methylation on an X-linked gene associated with a somatic male cancer.

UR - http://www.scopus.com/inward/record.url?scp=18244416617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244416617&partnerID=8YFLogxK

M3 - Article

VL - 60

SP - 3623

EP - 3630

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 13

ER -